Come see Daniel Dagenhart's research in the development of treatment for HCV. About 150-200 million people in the world are infected with Hepatitis C (HCV), a virus that leads to cirrhosis of the liver as well as hepatocellular carcinoma. In the United States, an estimated 3.2 million people are infected with this virus. There is no vaccine currently available, and current treatments are not completely effective. His poster presentation will show the research he has done in this topic.